An emerging strategy in preventing and treating airway allergy consists of modulating the
immune response induced against allergens in the lungs. CpG oligodeoxynucleotides have …

The physiochemical properties of drugs used in treating inflammation-associated lung
diseases (ie, asthma, chronic obstructive pulmonary disease, pulmonary fibrosis) play an …

Allergic rhinitis (AR) is the most common respiratory allergic disorder which results from an
IgE-mediated inflammation in the nasal mucosa. The first strategies for the controlling of AR …

Allergen-specific immunotherapy was introduced in clinical settings more than 100 years
ago. It remains the only curative approach to treating allergic disorders that ameliorates …

Nanoparticles in allergen immunotherapy : Current Opinion in Allergy and Clinical Immunology
Nanoparticles in allergen immunotherapy : Current Opinion in Allergy and Clinical Immunology …

The aim of the research presented here was to determine the characteristics and
immunostimulatory capacity, in vivo, of antigen and adjuvant co-loaded into microparticles …

The skewed T helper (Th) 2 response plays a critical role in the pathogenesis of allergic
asthma. Regulatory T (Treg) cells and the regulatory cytokines are required in maintaining …

Allergic diseases are characterized by the seasonally recurring production of T helper 2
(TH2) cytokines (eg, Interleukin [IL]-4, IL-5, and IL-13), which drive the production of allergen …

Allergic asthma is becoming increasingly prevalent in the developed world, and many
common allergens are capable of inducing allergic asthma responses, particularly in atopic …

Gene therapy is a promising strategy to deliver growth factors of interest locally in a
sustained fashion and has the potential to overcome barriers to using recombinant protein …